Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States
- 9 April 1992
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 69 (11) , 68-74
- https://doi.org/10.1016/0002-9149(92)90962-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacology of bepridilThe American Journal of Cardiology, 1992
- Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibersAmerican Heart Journal, 1986
- Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectorisThe American Journal of Cardiology, 1985
- Evaluation of bepridil for the treatment of angina pectoris: Evidence for preservation of left ventricular functionThe American Journal of Cardiology, 1985
- Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridilThe American Journal of Cardiology, 1985
- Pharmacokinetics and metabolism of bepridilThe American Journal of Cardiology, 1985
- Effects of Bepridil on exercise tolerance in chronic stable angina: A double-blind, randomized, placebo-controlled, crossover trialThe American Journal of Cardiology, 1984
- Bepridil for chronic stable angina pectoris: Results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patientsThe American Journal of Cardiology, 1983
- Evaluation of bepridil, a new antianginal agent: Clinical and hemodynamic alterations during the treatment of stable angina pectorisThe American Journal of Cardiology, 1983
- STUDIES ON THE BRADYCARDIA INDUCED BY BEPRIDILBritish Journal of Pharmacology, 1982